Absci (ABSI) Cash & Equivalents Growth (3y) (2023 - 2026)
Powered by 
Analysis
Absci (ABSI) Cash & Equivalents Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.80 Bn | 130.95 Bn | 2.84 Bn | -15.41% |
| 2 | Regeneron Pharmaceuticals | 85.54 Bn | 77.55 Bn | 3.93 Bn | 8.23% |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 47.78% |
| 4 | Moderna | 58.07 Bn | 52.93 Bn | 52.00 Mn | -23.18% |
| 5 | Revolution Medicines | 44.01 Bn | 44.01 Bn | - | - |
| 6 | BeOne Medicines | 39.98 Bn | 34.88 Bn | 1.53 Bn | 14.34% |
| 7 | Alnylam Pharmaceuticals | 35.40 Bn | 32.09 Bn | 992.69 Mn | 37.45% |
| 8 | Royalty Pharma | 28.40 Bn | 27.57 Bn | - | -27.97% |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | -3.85% |
| 10 | Absci | 1.39 Bn | 1.19 Bn | - | 20.89% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.89% |
| Mar 31, 2026 | -8.90% |
| Dec 31, 2025 | -30.62% |
| Sep 30, 2025 | -55.47% |
| Jun 30, 2025 | -43.06% |
| Mar 31, 2025 | -40.76% |
| Dec 31, 2024 | -45.35% |
| Sep 30, 2024 | -48.48% |
| Jun 30, 2024 | -24.42% |
| Dec 31, 2023 | 1.18% |